Baboon syndrome induced by cetuximab.
暂无分享,去创建一个
T. Jouary | A. Taieb | B. Milpied | Thomas Hubiche | Thomas Jouary | Veronique Sans | Denis Smith | Brigitte Milpied | Alain Taieb | T. Hubiche | V. Sans | Denis Smith
[1] E. Van Cutsem,et al. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] G. Girolomoni,et al. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. , 2003, The American journal of pathology.
[3] S. Yashar,et al. Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management. , 2007, Journal of the American Academy of Dermatology.
[4] R. Perez-soler,et al. Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] A. Bircher,et al. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? , 2004, Contact dermatitis.
[6] A. Bircher,et al. Systemically induced allergic exanthem from mercury , 2004, Contact dermatitis.
[7] Stephen W Dusza,et al. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. , 2006, Journal of the American Academy of Dermatology.